LUCULLI, GIOVANNA IRENE
 Distribuzione geografica
Continente #
NA - Nord America 226
AS - Asia 135
EU - Europa 92
SA - Sud America 23
AF - Africa 3
Totale 479
Nazione #
US - Stati Uniti d'America 219
SG - Singapore 48
CN - Cina 44
IT - Italia 41
BR - Brasile 19
HK - Hong Kong 16
DE - Germania 15
KR - Corea 12
NL - Olanda 10
FI - Finlandia 9
GB - Regno Unito 6
PL - Polonia 4
VN - Vietnam 4
CA - Canada 3
FR - Francia 3
CI - Costa d'Avorio 2
EC - Ecuador 2
IL - Israele 2
IN - India 2
MX - Messico 2
SE - Svezia 2
SV - El Salvador 2
AT - Austria 1
BD - Bangladesh 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
PE - Perù 1
PH - Filippine 1
RU - Federazione Russa 1
SN - Senegal 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 479
Città #
Dallas 118
Singapore 31
Ashburn 28
Santa Clara 18
Hong Kong 16
Hefei 15
Munich 12
Seoul 12
Shanghai 12
Boardman 7
Los Angeles 7
New York 7
Beijing 6
Florence 5
London 5
Pisa 5
Rome 5
Bagno a Ripoli 4
Lappeenranta 4
Warsaw 4
Ho Chi Minh City 3
Milan 3
Turku 3
Abidjan 2
Cascina 2
Catania 2
Fort Worth 2
Frankfurt am Main 2
Helsinki 2
Montreal 2
Redondo Beach 2
San Salvador 2
Almaty 1
Ankara 1
Ashta 1
Beirut 1
Bexley 1
Brasília 1
Brooklyn 1
Cagliari 1
Campo Grande 1
Chennai 1
Conquista 1
Curaçá Municipality 1
Dakar 1
Denver 1
Franklin 1
Goianira 1
Guarulhos 1
Hanoi 1
Ilhéus 1
Itabaiana 1
Itabuna 1
Itaperuna 1
Lauterbourg 1
Lima 1
Lorena 1
Manoel Ribas 1
Marseille 1
Marumbi 1
Mesquita 1
Mexico City 1
Montevideo 1
North Charleston 1
Nuremberg 1
Ogden 1
Orem 1
Portoviejo 1
Prato 1
Querétaro 1
Rahat 1
Ribeirão Preto 1
Rio de Janeiro 1
Springfield 1
Stockholm 1
São José da Bela Vista 1
São Paulo 1
Taipei 1
Tampa 1
Tokyo 1
Viamão 1
Totale 397
Nome #
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 154
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 136
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 110
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 84
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era 5
Totale 489
Categoria #
all - tutte 1.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20239 0 0 0 0 0 0 0 0 7 0 2 0
2023/202426 1 2 1 0 0 4 1 1 1 1 7 7
2024/2025185 1 4 7 7 17 21 14 14 19 16 30 35
2025/2026269 32 70 86 31 26 24 0 0 0 0 0 0
Totale 489